A recent study assessed whether interdisciplinary care has a role in treating dyspareunia and if any baseline predictors of severity of deep dyspareunia can be identified.
Results of a small study of ospemifene provide direct evidence of the effect of the drug on vaginal tissue, according to the authors.
A relatively new laparoscopic technique, which entails use of the pelvic peritoneum to increase vaginal length, may be an effective treatment for dyspareunia.
CO2 laser therapy improved GSM in this retrospective study.
The most important component of caring for women who report painful sexual exchange with vaginal penetration is for the clinician to simply bring up the topic during an office visit, according to one ob/gyn.
A recent study examined similarities and differences between women who were exposed to sexual abuse and those with dyspareunia and is the first to actively compare these groups.
The model focuses on helping clinicians identify “causes and consequences” of dyspareunia and nonpharmacologic self-care interventions.
A new study highlighted how common sexual dysfunction is among middle-aged persons and if the prevalence among Canadians is consistent with American and British reports.
A recent study quantified how much the treatment effect of pharmacologic modalities for female sexual dysfunction could be attributed to the placebo effect.
Dilator therapy can be extremely successful in treating superficial dyspareunia, but compliance is often poor. A new type of vaginal dilator that gives women more control aims to address the issue.